Cellevolve
CEO: Derrell Porter, MD
Cellevolve Bio is a development and commercialization company focused on cell therapies. The Company’s mission is to partner with innovators to translate early-stage clinical therapies into commercially available treatments for neglected diseases, including pediatric and rare diseases, which can have a major impact if they are advanced into clinical development and beyond. The Company is addressing this need with its partnering development approach and its integrated Cellution™ platform, which translates breakthrough science into powerful new therapies for patients.